<DOC>
	<DOCNO>NCT00912886</DOCNO>
	<brief_summary>The steroid pregnenolone sulfate ( PREGS ) may one factor responsible memory decline relate normal age associated Alzheimer 's disease ( AD ) . The purpose study determine whether plasma level PREGS decrease patient mild moderate AD compare AD-free control subject match gender age see whether inversely correlate severity memory deficit AD patient . The hypothesis blood level PREGS decrease advanced age stage AD would positively correlated memory deficit . Therefore PREGS could consider early marker memory deficit AD .</brief_summary>
	<brief_title>Pregnenolone Sulfate Early Marker Memory Loss Alzheimer 's Disease</brief_title>
	<detailed_description>PREGS derivative pregnenolone obligatory precursor steroid hormone originate gonad adrenal gland . In rodent , PREGS demonstrate improve memory performance various behavioural test . In human , PREGS one abundant circulating steroid . There indication decrease blood aging , brain sample age patient AD , low concentration PREGS correlate high level beta-amyloid peptide phosphorylated tau protein . To date , precise rigorous evaluation PREGS blood concentration age lack relationship concentration memory loss associate AD establish . Primary objective To show plasma concentration PREGS decrease AD patient ( `` case `` ) compare free-AD subject ( `` control `` ) , match gender age . Secondary objective - To show plasma concentration PREGS inversely correlate severity memory deficit AD patient . - To show plasma concentration PREGS correlate memory score control . - To show plasma concentration PREGS decrease control . - To search relationship PREGS metabolites age severity memory deficit . This case-control study comprise 200 subject age 70 year , include 100 outpatient mild moderate AD 100 AD-free volunteer control match age gender . These two group stratify age-sub-groups [ 70-74 ] [ 75-79 ] [ 80-84 ] [ 85-89 ] &gt; 90 year include 10 men 10 woman per sub-group . AD patient control enrolled evaluate geriatric centre 5 hospital namely BICETRE , BROCA , PAUL BROUSSE , PITIE-SALPETRIERE ROTHSCHILD . They submit clinical examination , biological analysis , cognitive test brain magnetic resonance imaging scan . Blood collect subject steroid analysis gas chromatography-mass spectrometry , sensitive accurate methodology allow simultaneous quantification several steroid individual sample . PREGS metabolites identify quantified `` Institute medical heath '' ( INSERM U788 ) .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Memory Disorders</mesh_term>
	<criteria>Subjects age 70 year sign informed consent participation study affiliate social security regimen . For patient : subject probable AD accord DSMIV criterion NINCDS/ADRDA criterion mild moderate probable AD : MMSE score &gt; 15 . For Controls : subject without cognitive deficit neuropsychological test : score MMSE &gt; 26 5 Word test equal 10/10 Clock Drawing test equal 7/7 . Guardianship History cerebrovascular disease , Parkinson 's disease , know dementia , epilepsy Major depression Serious sensory disorder ; deficit language &amp; comprehension Serious heart hepatic insufficiency , renal respiratory failure Unstable diabetes endocrine disorder , thyroid dysfunction , cancer , inflammatory syndrome , malnutrition Cognitive training 6 previous month Medications : steroid ( HRT , androgens , corticoid ) , antidepressant , cholinesterase inhibitor , thyroid hormone , synthetic antithyroids Contraindications MRI : metallic implant &amp; claustrophobia</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>alzheimer</keyword>
	<keyword>memory</keyword>
	<keyword>neurosteroids</keyword>
</DOC>